Citation Tools

Download PDFPDF
PS-072 Incidence, management and cost of Telaprevir/Boceprevir-Induced thrombocytopenia during the first 12 weeks of treatment in patients with hepatitis C

Download to a citation manager

Cite this article as:
Gómez-Álvarez S, Guglieri-López B, Ventura-Cerdá J, et al
PS-072 Incidence, management and cost of Telaprevir/Boceprevir-Induced thrombocytopenia during the first 12 weeks of treatment in patients with hepatitis C